Washington University School Of Medicine

3 trials Academic / non-commercial

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

2 Completed trials

6 Countries active

5 Unique IMPs

100% Results reported

Phase II/III

Phase III/IV

Phase II/III: 2 Phase III/IV: 1

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

LECANEMAB 2 N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE 2 E2814 1 FLORQUINITAU (18F) 1 LY3372993 1

All trials

3 total

A Study of Treatments for the Prevention of Disease Progression in Individuals at Risk for or With Early Onset Alzheimer’s Disease Caused by… Pending

2024-517187-36-01 Phase II/III 4 countries LY3372993; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Early… Ended

2024-515198-91-00 Phase II/III 5 countries E2814; FLORQUINITAU (18F); LECANEMAB; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROX…
The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab … Ended

2024-513458-31-00 Phase III/IV 1 country LECANEMAB

Showing 1–3 of 3 trials

← All sponsors A–Z